Melanoma: a new Targeted Therapy (Anti-PD1, Nivolumab; Opdivo)
Off
Nivolumab in previously untreated melanoma without BRAF mutation. Robert C. et al. N Engl J Med. 2015 Jan 22;372(4):320-30. doi: 10.1056/NEJMoa1412082. Epub 2014 Nov 16. INTRODUCTION Malignant Melanoma (MM) is the most deadly of skin cancers and advanced melanomas need... READ MORE